Press release
Primary Catalyst Driving Chronic Venous Occlusions Treatment Market Evolution in 2025: Rising Obesity Rates Fuel Growth In The Chronic Venous Occlusion Treatment Market Driver
What Is the Future Outlook for the Chronic Venous Occlusions Treatment Market's Size and Growth Rate?The chronic venous occlusions treatment market has experienced significant growth in recent years. It will rise from $6.7 billion in 2024 to $7.19 billion in 2025, at a CAGR of 7.3%. Growth in the historic period can be attributed to investments in innovative treatments, the increase in venous disorder cases, improved diagnosis and awareness, clinical trials, research efforts, and better patient outcomes and quality of life.
The chronic venous occlusions treatment market is expected to see strong growth, reaching $9.32 billion by 2029 at a CAGR of 6.7%. This growth is attributed to increased awareness of venous disorders, rising demand for minimally invasive procedures, an aging population, advancements in endovascular therapies, and a focus on patient-centric care. Major trends include innovations in minimally invasive procedures, technological advancements in interventional radiology, focus on endovascular therapies, growing venous disorder prevalence, and the aging population.
What Is Stimulating Growth in the Chronic Venous Occlusions Treatment Market?
The increasing prevalence of obesity is anticipated to drive the growth of the chronic venous occlusion treatment market. Obesity, defined by a body mass index (BMI) of 30 or higher, is a medical condition characterized by excessive body fat. Chronic venous occlusion treatments help manage obesity-related symptoms like edema and skin changes by improving blood circulation and reducing inflammation, thus contributing to better obesity management. For example, the World Heart Federation, a Switzerland-based global cardiovascular organization, reported in March 2023 that approximately 2.3 billion adults and children were obese or overweight globally, and this number is expected to rise to 2.7 billion by 2025. Hence, the increasing incidence of obesity is driving the growth of the chronic venous occlusion treatment market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13286&type=smp
Which Key Market Leaders Are Driving Chronic Venous Occlusions Treatment Industry Growth?
Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA
What Are the Emerging Trends in the Chronic Venous Occlusions Treatment Industry?
In the chronic venous occlusion treatment market, companies are focusing on innovative solutions like implantable medical devices to treat venous outflow obstruction in chronic venous insufficiency (CVI) patients. An implantable medical device is surgically inserted into the body for long-term use, often for diagnosing or treating conditions. For example, in June 2024, Koninklijke Philips N.V. (Philips), a Netherlands-based technology company, launched the Duo Venous Stent System, an implantable device designed to treat CVI. Its dual-layer design enhances flexibility and radial strength, while its advanced coating improves biocompatibility and reduces thrombosis risk. The precise delivery system ensures accurate placement in complex anatomical conditions.
What Are the Main Segments in the Chronic Venous Occlusions Treatment Market?
The chronic venous occlusions treatment market covered in this report is segmented -
1) By Product: Devices, Drugs
2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users
Subsegments:
1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons, Other Interventional Devices
2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs, Other Pharmacological Treatments
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chronic-venous-occlusions-treatment-global-market-report
Which Geographic Area Leads the Chronic Venous Occlusions Treatment Market?
North America was the largest region in the chronic venous occlusions treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Chronic Venous Occlusions Treatment Global Market Report?
- Market Size Analysis: Analyze the Chronic Venous Occlusions Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Chronic Venous Occlusions Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Chronic Venous Occlusions Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Chronic Venous Occlusions Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13286
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving Chronic Venous Occlusions Treatment Market Evolution in 2025: Rising Obesity Rates Fuel Growth In The Chronic Venous Occlusion Treatment Market Driver here
News-ID: 3849656 • Views: …
More Releases from The Business Research Company

Shaping the Megatope Market in 2025: Rising Cancer Incidence And Its Impact On T …
How Big Is the Megatope Market Expected to Be, and What Will Its Growth Rate Be?_x000D_
In recent times, the megatope market has demonstrated a size increase of $XX (CAGR). Predictions indicate its growth from $XX million in 2024 to $XX million in 2025, exhibiting a compound annual growth rate (CAGR) of $XX%. The historical period's growth seems to be a result of elevated incidences of chronic illnesses, a surge in…

Leading Growth Driver in the Viltepso Market in 2025: Impact Of Increasing Duche …
What Are the Market Size and Growth Forecast for the Viltepso Market?_x000D_
In the previous years, the market size for Viltepso has expanded by $XX (CAGR). A surge from $XX million in 2024 to $XX million by 2025 is expected, representing a Compound Annual Growth Rate (CAGR) of $XX%. The escalation observed in the historic period is a result of factors such as enhanced research funding and undertakings, heightened awareness and…

Xenpozyme Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Em …
How Is the Xenpozyme Market Projected to Grow, and What Is Its Market Size?_x000D_
In recent times, the xenpozyme market has achieved an $XX (CAGR). Predictions suggest an escalation from $XX million in 2024 to $XX million in 2025, with the compound annual growth rate (CAGR) noted at $XX%. The growth observed over the historic period is believed to be influenced by factors such as the growing incidence of rare genetic…

A Deep Dive into PENBRAYA Market 2025: Key Drivers, Growth Factors, and Projecti …
What Is the Expected Size and Growth Rate of the PENBRAYA Market?_x000D_
The dimensions of the PENBRAYA market have recently seen an $XX (CAGR) surge. It's projected to evolve from a $XX million net worth in 2024 to an impressive $XX million in 2025, exhibiting a compound annual growth rate (CAGR) of $XX%. Several factors have catalyzed this growth during the historical phase, including escalated immunization rates, augmented availability of vaccines,…
More Releases for Venous
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction
According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,…
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.
Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188
Pulmonary embolism occurs in almost one-third of patients…
Venous Thromboembolism Treatment Market Analysis by 2028
Global Venous Thromboembolism Treatment Market: Overview
When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts. A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing…
Venous Syringe Market Size, Share, Development by 2025
Market Research Report Store offers a latest published report on Venous Syringe Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Venous Syringe players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/1021886/global-venous-syringe-market-insights
The…
Continuous Renal Replacement Therapy (CRRT) Market Report 2018: Segmentation by …
Global Continuous Renal Replacement Therapy (CRRT) market research report provides company profile for Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., Nipro Corporation, NIKKISO CO., LTD., Toray Medical Company Limited, INFOMED SA and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018…
Venous Thromboembolism Market - Global Industry Analysis 2025
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism.
Request to download and…